Clara C. Hildebrandt, MD and Jonathan M. Marron, MD, MPH
Gene editing with CRISPR/Cas9 raises concerns about equitable access to therapies that could limit research participation by minority group members. These concerns can be addressed through public education, transparency, and stakeholder partnerships.
AMA J Ethics. 2018;20(9):E826-833. doi:
10.1001/amajethics.2018.826.
Dr Lisa Fuller joins Ethics Talk to discuss her article: “How Should Organizations and Clinicians Help Marginalized Patients Manage Loneliness as a Harm of Climate Change?”
Dr Elena Portacolone joins Ethics Talk to discuss her article, coauthored with Daisy Elise Feddoes: “Should Artificial Intelligence Play a Role in Cultivating Social Connections Among Older Adults?”
Dr Patricia Luck joins Ethics Talk to discuss her article, coauthored with Arman M. Niknafs: “Reasons Not to Turf a Patient Whose ‘Belonging’ in a Hospital Is Unclear.”
Dr Christy A. Rentmeester joins Ethics Talk to discuss her article: “How to Gird Up ‘Watch One, Do One, Teach One’ for the Moral Psychological Demands of Just Action.”